Supreme Court: "Roop Amrit" & "Complete Solution" classified as cosmetic/toilet prep, SSI exemption upheld

The Supreme Court classified "Roop Amrit" and "Complete Solution" as cosmetic/toilet preparations under heading 3304, not Ayurvedic medicines. Valuation was done under Section 4A, and SSI exemption for the Indore unit was upheld. The demand for the extended period was sustained, but penalties on partners were set aside. The appeals were partly allowed, with the cross-objection disposed of accordingly.

---

---

Issues Involved:
1. Correct classification of "Roop Amrit" and "Complete Solution" – whether Ayurvedic medicines or cosmetic/toilet preparations.
2. Valuation of the products – under Section 4 or Section 4A.
3. Availability of SSI exemption for the appellant-assessee for the period when the unit was located in Indore.
4. Sustainability of demand for the extended period and imposition of penalties on the appellant-assessee and partners.

Issue-wise Detailed Analysis:

1. Classification of "Roop Amrit" and "Complete Solution":
The main issue was whether "Roop Amrit" and "Complete Solution" should be classified as Ayurvedic medicines under heading 3003 or as cosmetic/toilet preparations under heading 3304. The original authority classified these products as Ayurvedic medicines based on their registration with the Drug Controller and the ingredients listed in authoritative Ayurvedic texts. However, upon review, it was determined that the products were marketed for cosmetic purposes, such as enhancing appearance and beauty. The Supreme Court's decisions in similar cases (e.g., Alpine Industries vs. Collector, Central Excise, Shree Baidyanath Ayurved Bhavan Ltd. vs. CCE) emphasized that products with subsidiary curative properties but primarily used for cosmetic purposes should be classified under Chapter 33. Thus, the products were ultimately classified under heading 3304 as cosmetic/toilet preparations.

2. Valuation of Products:
Since the products were classified as cosmetic or toilet preparations, their valuation had to be done under Section 4A of the Central Excise Act, 1944, in accordance with Notification No. 13/2002-CE (NT) dated 01.03.2002. This section pertains to the valuation of goods based on the retail sale price.

3. Availability of SSI Exemption:
The appellant-assessee claimed SSI exemption for the period when the unit was located in Indore, supported by certificates from local authorities confirming the rural location of the factory. The denial of SSI exemption by the lower authorities was found to be unsustainable, as the appellant-assessee had provided sufficient evidence to qualify for the exemption.

4. Sustainability of Demand for Extended Period and Imposition of Penalties:
The appellant-assessee contested the demand for the extended period, arguing a bona fide belief that their products were Ayurvedic medicines. However, the tribunal found that mere bona fide belief was insufficient to avoid the extended period demand. The appellant-assessee had not sought clarification from the Central Excise authorities regarding the correct classification or duty liability. Consequently, the demand for the extended period was upheld. However, penalties imposed on the partners of the appellant firm were set aside, as penalties equal to the duty amount had already been imposed on the firm, and the Commissioner (Appeals) had previously set aside these penalties.

Conclusion:
The appeals filed by the Revenue and the appellant-assessee were partly allowed. The products were classified as cosmetic/toilet preparations under heading 3304, valued under Section 4A. The SSI exemption for the Indore unit was upheld, but the demand for the extended period was sustained. Penalties on the partners were set aside. The cross-objection was disposed of accordingly.

Pronounced on 05.10.2016.

---